Lombard Odier Asset Management Europe Ltd Invests $9.53 Million in Chemed Co. (NYSE:CHE)

Lombard Odier Asset Management Europe Ltd acquired a new stake in Chemed Co. (NYSE:CHEFree Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 17,572 shares of the company’s stock, valued at approximately $9,534,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Rise Advisors LLC acquired a new stake in shares of Chemed during the first quarter worth $26,000. GAMMA Investing LLC lifted its stake in Chemed by 34.4% in the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after buying an additional 22 shares in the last quarter. Mather Group LLC. purchased a new stake in shares of Chemed in the first quarter valued at $67,000. EntryPoint Capital LLC boosted its stake in shares of Chemed by 14.0% during the 1st quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock worth $94,000 after purchasing an additional 18 shares during the last quarter. Finally, Janiczek Wealth Management LLC boosted its position in Chemed by 154.5% during the first quarter. Janiczek Wealth Management LLC now owns 196 shares of the company’s stock worth $126,000 after acquiring an additional 119 shares during the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Chemed

In other Chemed news, Director Andrea R. Lindell sold 831 shares of Chemed stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $571.51, for a total value of $474,924.81. Following the transaction, the director now owns 5,725 shares in the company, valued at $3,271,894.75. The transaction was disclosed in a document filed with the SEC, which is available at this link. In related news, Director Andrea R. Lindell sold 831 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $571.51, for a total transaction of $474,924.81. Following the transaction, the director now directly owns 5,725 shares of the company’s stock, valued at $3,271,894.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $569.63, for a total value of $1,139,260.00. Following the completion of the transaction, the chief executive officer now owns 105,735 shares in the company, valued at approximately $60,229,828.05. The disclosure for this sale can be found here. In the last three months, insiders sold 6,744 shares of company stock valued at $3,828,231. Company insiders own 3.32% of the company’s stock.

Chemed Price Performance

NYSE CHE opened at $582.06 on Monday. The company has a market cap of $8.81 billion, a P/E ratio of 31.33, a P/E/G ratio of 2.31 and a beta of 0.44. Chemed Co. has a 12 month low of $497.36 and a 12 month high of $654.62. The company has a 50-day moving average of $569.34 and a 200-day moving average of $577.23.

Chemed (NYSE:CHEGet Free Report) last issued its quarterly earnings data on Wednesday, July 24th. The company reported $5.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.59 by ($0.12). The firm had revenue of $595.88 million during the quarter, compared to analyst estimates of $599.20 million. Chemed had a net margin of 12.88% and a return on equity of 29.21%. The firm’s revenue was up 7.6% compared to the same quarter last year. During the same period last year, the business earned $4.71 EPS. As a group, equities research analysts anticipate that Chemed Co. will post 21.77 EPS for the current year.

Chemed Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 12th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, August 12th. This is an increase from Chemed’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. Chemed’s payout ratio is currently 10.76%.

About Chemed

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

See Also

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.